Neuroprotective and anticancer effects of 7‑Methoxyheptaphylline via the TAK1 pathway

Keyphrases

• Anticancer Effect 100%
• Cell Death 100%
• Neuroprotective Effect 100%
• SH-SY5Y Cells 100%
• TAK1 100%
• HT-29 100%
• Cancer Cells 66%
• Glycogen Synthase Kinase 3 (GSK3) 66%
• LNCaP Cells 66%
• Anti-apoptotic Proteins 66%
• Caspase-3 66%
• 4T1 Cells 66%
• Neuronal Cell Death 66%
• Induced Apoptosis 33%
• Flow Cytometry 33%
• In Cancer 33%
• Metastasis 33%
• Western Blot Analysis 33%
• Medicinal Plants 33%
• Matrix metalloproteinase-9 (MMP-9) 33%
• Headache 33%
• Hydrogen Peroxide 33%
• MTT Assay 33%
• HepG2 Cells 33%
• Anticancer Activity 33%
• Molecular Targets 33%
• Molecular Docking 33%
• Anti-metastasis 33%
• Molecular Docking Analysis 33%
• Induced Neuronal Cells 33%
• Carbazole 33%
• Stomachache 33%
• Clausena Harmandiana 33%
• MAPK13 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Phosphotransferase 100%
• Neuroprotective Agent 100%
• Malignant Neoplasm 66%
• Antiapoptotic 66%
• Hydrogen Peroxide 66%
• Western Blot 33%
• Flow Cytometry 33%
• Molecular Target 33%
• Headache 33%
• Synthetase 33%
• Clausena 33%
• Glycogen Synthase Kinase 33%
• Carbazole Derivative 33%
• Medicinal Plant 33%

Biochemistry, Genetics and Molecular Biology

• Cell Death 100%
• Anticancer 100%
• Kinase 60%
• Phosphotransferase 60%
• Cancer Cell 40%
• Docking (Molecular) 40%
• LNCaP 40%
• Hydrogen Peroxide 40%
• Animal Model 20%
• MTT Assay 20%
• STAT3 20%
• Antineoplastic Activity 20%
• Synthase 20%
• Medicinal Plant 20%
• GSK-3 20%
• Clausena 20%
• Flow Cytometry 20%
• Western Blotting 20%